ISPO

Follow-up Markers

Endometrial carcinoma: Advent of molecular staging

KC Podratz MD PhD , TJ Sebo MD PhD , GL Keeney MD , PC Roche

Immunohistochemical detection of the proto-oncogene eIF4E in surgical margins of head and neck cancer patients may predict recurrence

CO Nathan MD, SW Franklin MD, FW Abreo MD, R Nassar PhD

Mutagenesis and genotoxicity of the 1-nitropyrene-DNA adduct N-(deoxyguanosin-8-yl)-1-amino-pyrene are dependent on the DNA sequence context

AK Basu, MD Bacolod

Identification of high risk patients with locally advanced nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy

Skye Hongiun Cheng, MD, James Jer-Min Jian, MD, Stella YC Tsai, MD, Lawrence K Yen, MD, Nei-Min Chu, MD , Szu-Yun Leu, MS, Kwan-Yee Chan, MD , Tran-Der Ta

Sensitive detection of liver, pancreatic, gastric and colorectal cancer cells in blood by reverse transcription followed by polymerase chain reaction

N O Funaki MD PhD , J Tanaka MD PhD , M Imamura MD PhD , H Takeda MD PhD , G Ohshio MD PhD , A Nonaka MD PhD , F Totsumoto MD PhD

Thyroperoxidase(TPO): A tumor marker for post-therapeutic follow-up of differentiated thyroid carcinomas? Results of a time course study

W-G Franke MD, K Zöphel MD, G Wunderlich PhD, A Kühne MD, C Schimming MD, J Kropp MD, J Bredow MD